BBIO

NASDAQStock

BridgeBio Pharma, Inc.

$68.82-2.76 (-3.87%)

52-Week Range

$30.14

$79.91

Key Stats

Market Cap

13.3B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Volume

1.6M

Avg Volume

3.3M

Performance

-1.49%

-5.00%

+38.70%

YTD

-8.75%

+119.05%

+391.33%

+2.15%

Price Chart

ETF Exposure

BBIO is held by 120 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDH	iShares LifePath Target Date 2060 ETF	0.01%	56	$4K	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.01%	43	$3K	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.01%	19	$1K	$9.5M	0.12%
ITDF	iShares LifePath Target Date 2050 ETF	0.01%	103	$8K	$59.0M	0.11%
JHML	John Hancock Investments - Multifactor Large Cap ETF	0.01%	884	$58K	$1.05B	0.32%
ITDE	iShares LifePath Target Date 2045 ETF	0.01%	87	$6K	$64.1M	0.11%
EAOA	iShares ESG Aware 80/20 Aggressive Allocation ETF	0.00%	38	$3K	$33.4M	0.34%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	26	$2K	$30.3M	0.32%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	75	$6K	$81.7M	0.11%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	4	$285	$9.0M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	5	$352	$8.3M	0.31%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	44	$3K	$81.5M	0.10%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	13	$994	$61.4M	0.09%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	6	$445	$694.1M	0.23%
IQSM	NYLI Candriam U.S. Mid Cap Equity ETF	0.00%	12,282	$0	$207.8M	0.15%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,065	$81K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,065	$81K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,065	$81K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,065	$81K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,065	$81K	$3.7M	0.70%

PreviousPage 3 of 3

About BBIO ETF Exposure

BridgeBio Pharma, Inc. (BBIO) is held by 120 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 13.3B, BBIO is a widely held institutional stock. The stock currently trades at $68.82. Investors can gain exposure to BBIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BBIO, sorted by portfolio weight.